Abstract:
Canova is a homeopathic complex medicine, used as an immune modulator. We
studied its effects in normal and sarcoma 180-bearing mice. Three control groups were
also evaluated. The mice were examined at daily intervals and the tumours observed
histologically. Peripheral blood was analysed by flow cytometry.
A delay in the development, and a reduction in size of the tumours, and increased
infiltration by lymphoid cells, granulation tissue, and fibrosis surrounding the tumour
were observed with active treatment compared to control. All animals from the treated
group survived, 30% of control groups died. In 30% of treated animals, a total
regression of the tumour was confirmed using light microscopy, no regression was
found in the control groups. Treatment with Canova increased total numbers of
leukocytes and lymphocytes. Among lymphocytes, TCD4, increased in normal-treated
group and B and NK cells in S180-treated groups. The results reflect enhanced immune
response of the host after treatment with Canova.
